Milnacipran clinical trials
Also written Savella.
How each study uses Milnacipran is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 14 Jan 2009 · SAVELLA · NDA 022256 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
41 studies that test it; most in 2010 (12)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 12 |
| 2011 | 12 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 28
Forest Laboratories (8) · Duke University (3) · Pierre Fabre Medicament (3) · Brigham and Women's Hospital (2) · Samsung Medical Center (2) · University Hospital, Clermont-Ferrand (1) · Timothy Smith (1) · Montefiore Medical Center (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Analgesics, Non-Narcotic source
- One of SNRIs source
- Levomilnacipran is one of its enantiomers, counted on its own page source
Studies
Open first, then newest update. How each study uses Milnacipran is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 41
- Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia TherapyCompletedPhase 2University Hospital, Clermont-FerrandNCT01747044Written as MilnacipranHow we know
- Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over TrialCompletedPhase 3Duke UniversityNCT01829243Written as MilnacipranHow we know
- Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic MigraineCompletedNot applicableTimothy SmithNCT01393522Written as MilnacipranHow we know
- Effect of Milnacipran / Gabapentin in FibromyalgiaStatus unknownNot applicableMansoura UniversityNCT05384210Written as MilnacipranHow we know
- A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy PainTerminatedPhase 3Columbia UniversityNCT01288937Written as MilnacipranHow we know
- Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme SyndromeTerminatedNot applicableNew York State Psychiatric InstituteNCT02687165Written as Milnacipran and D-cycloserineHow we know
- Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of AutismCompletedPhase 4Montefiore Medical CenterNCT01337700Written as MilnacipranHow we know
- Study of Fibromyalgia Treated With MilnacipranCompletedPhase 4Albany Medical CollegeNCT01125423Written as MilnacipranHow we know
- Effect of Milnacipran on Pain in FibromyalgiaCompletedPhase 4University of California, San DiegoNCT01288807Written as MilnacipramHow we know
- The Effects of Milnacipran on Sleep Disturbance in FibromyalgiaCompletedPhase 4Mansoor Ahmed M.D.NCT01234675Written as MilnacipranHow we know
- Safety and Efficacy of Milnacipran in Pediatric Patients With Primary FibromyalgiaTerminatedPhase 2Forest LaboratoriesNCT01328002Written as MilnacipranHow we know
- Savella in Treatment for Provoked VestibulodyniaCompletedPhase 3University of TennesseeNCT01304589Written as MilnacipranHow we know
- Milnacipran for Treatment of Pain in Older Adults With Rheumatoid ArthritisCompletedPhase 4University of California, Los AngelesNCT01225991Written as MilnacipranHow we know
- A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With FibromyalgiaCompletedPhase 4University of MichiganNCT01173055Written as milnacipranHow we know
- Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)TerminatedPhase 2Spencer Dorn, MD, MPHNCT01471379Written as MilnacipranHow we know
- Pain Assessment and Quality of Life in Back Pain Patients: Role of MilnacipranWithdrawnPhase 3Brigham and Women's HospitalNCT01221740Written as SavellaHow we know
- The Effect of Milnacipran in Patients With FibromyalgiaCompletedPhase 2/3Beth Israel Medical CenterNCT01108731Written as MilnacipranHow we know
- Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed PatientsStatus unknownNot applicableSamsung Medical CenterNCT01352572Written as antidepressant responseHow we know
- Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic PhenotypeStatus unknownNot applicableSamsung Medical CenterNCT01352559Written as respondersHow we know
- The Effect of Milnacipran on Fatigue and Quality of Life in Lupus PatientsWithdrawnPhase 4Loma Linda UniversityNCT01359826Written as MilnacipranHow we know
See all 41 studies that test Milnacipran →
Given beside what is tested · 1 — Milnacipran is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Milnacipran
- Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With SciaticaStatus unknownPhase 2Rambam Health Care CampusNCT01914042Written as MilnacipranHow we know
- Drug and Talk Therapy for FibromyalgiaCompletedPhase 4Indiana UniversityNCT01038323Written as Educational with milnacipranHow we know
Codes
What other systems call Milnacipran · ClinicalTrials.gg INT006834
- MeSH (NLM) D000078764MilnacipranConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) G56VK1HF36MILNACIPRANConfirmed FDA, NLM, Wikidata
- RxNorm 588250Confirmed FDA, Wikidata
- Wikidata Q421058milnacipranConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78021MilnacipranOne source FDA
- DrugBank DB04896One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078764 | Milnacipran | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | G56VK1HF36 | MILNACIPRAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 588250 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421058 | milnacipran | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78021 | Milnacipran | One source FDA |
| DrugBank | DB04896 | — | One source Wikidata |
Also registered as milnacipran hydrochloride (UNII RNZ43O5WW5 · RxNorm 30003).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.